A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
Genmab
Genmab
National Institutes of Health Clinical Center (CC)
University of Nebraska
The First Affiliated Hospital with Nanjing Medical University
SCRI Development Innovations, LLC
Medstar Health Research Institute
Universität des Saarlandes
Seagen Inc.
The First Affiliated Hospital with Nanjing Medical University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Southern California
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Fundación Leucemia y Linfoma, Spain
Hoag Memorial Hospital Presbyterian
National Cancer Institute (NCI)
National Cancer Institute (NCI)
SWOG Cancer Research Network
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Heidelberg University
The Alvin and Lois Lapidus Cancer Institute